Laser Hair Removal in Beaumont CA
Unwanted hair in various body parts may impair ones quality of life. Men and women often feel embraced and uncomfortable having extra hair. It also affects self-confidence and personal relationships. Laser hair removal is relatively a new technique allowing effective, gentle and rapid hair removal. Each person has about 5 million hair follicles, they have different distribution, texture and color, all this factors should be taken under consideration when deciding to use laser hair removal technique. The ideal candidates for this procedure are people with light skin and dark hair. For those people fewer treatments are required to get better results. Dark and coarse hair absorbs energy most effectively; red or blond hair is very difficult to remove. Tanned people with light hair and tanned people with dark hair cannot be treated with usual laser they need a specialized laser technique. People with very dark pigmented skin also cannot be treated using a laser this because they absorb too much energy.
Contraindications for laser hair removal include people with underlying endocrine disorder, people with chronic or active herpes need antiviral treatment before the removal, patients with a history of hyperthrophic scarring, patients taking photosensitizing drugs. Patients with tattoos in the selected areas for hair removal should be informed that laser might change the appearance of the tattoos.
The idea behind hair removal is to destroy hair follicle and thus to prevent future hair growth. Laser is a wave of light energy targeted at specific sites. The wavelength varies; this allows targeting the wave energy specifically to hair follicles sparing the surrounding tissue. This method is called selective photodermolysis. All areas of the body with unwanted hair except around the eyes may be treated. Usually several treatment required to achieve maximal results, this is due to the fact that hair growth in a cyclic matter and laser energy affects only the growing hair. A minimum of 5 treatments usually required each of them 1-3 month apart. Complications of this procedure include skin blistering, skin changes hyper or hypopigmentation, scarring and thrombophlebitis. People with dark skin are more prone to develop the above side effects.
Immediately after the procedure ice packs are given to reduce swelling. Corticosteroid cream may also be applied. Minor skin damage can be treated with topical antibiotics cream. The response to treatment is highly individual; therefore it is difficult to predict the outcome for each patient
More Beaumont info...
Beaumont See
Texas Energy Museum, 600 Main Street, ? +1 409-833-5100 (info@texasenergymuseum.org, fax: +1 409-833-4282), [1]. Tu-Sa 9AM-5PM; Su 1PM-5PM. $2/1 (Adults/Seniors 65+ & Children under 12).
Plastic Surgery News...
- Phosphagenics Limited ("Phosphagenics") (ASX: POH; AIM: PSG; OTCQX: PPGNY) announced the initiation of a human clinical trial for its lead dermatological product, retinoic acid, a form of vitamin A. This trial represents the Company's first clinical trial to take place in the U.S. and denotes the commencement of the Company's planned expansion into targeted, non-systemic delivery of drugs.
Context Comorbidities may increase the negative effects of specific anticancer treatments such as androgen suppression therapy (AST).
Objectives To compare 6 months of AST and radiation therapy (RT) to RT alone and to assess the interaction between level of comorbidity and all-cause mortality.
Design, Setting, and Patients At academic and community-based medical centers in Massachusetts, between December 1, 1995, and April 15, 2001, 206 men with localized but unfavorable-risk prostate cancer were randomized to receive RT alone or RT and AST combined. All-cause mortality estimates stratified by randomized treatment group and further stratified in a postrandomization analysis by the Adult Comorbidity Evaluation 27 comorbidity score were compared using a log-rank test.
Main Outcome Measure Time to all-cause mortality.
Results As of January 15, 2007, with a median follow-up of 7.6 (range, 0.5-11.0) years, 74 deaths have occurred. A significant increase in the risk of all-cause mortality (44 vs 30 deaths; hazard ratio [HR], 1.8; 95% confidence interval [CI], 1.1-2.9; P = .01) was observed in men randomized to RT compared with RT and AST. However, the increased risk in all-cause mortality appeared to apply only to men randomized to RT with no or minimal comorbidity (31 vs 11 deaths; HR, 4.2; 95% CI, 2.1-8.5; P < .001). Among men with moderate or severe comorbidity, those randomized to RT alone vs RT and AST did not have an increased risk of all-cause mortality (13 vs 19 deaths; HR, 0.54; 95% CI, 0.27-1.10; P = .08).
Conclusions The addition of 6 months of AST to RT resulted in increased overall survival in men with localized but unfavorable-risk prostate cancer. This result may pertain only to men without moderate or severe comorbidity, but this requires further assessment in a clinical trial specifically designed to assess this interaction.
Trial Registration clinicaltrials.gov Identifier: NCT00116220